Avenue Biosciences
Avenue Biosciences is a biotechnology company developing a platform to improve protein production efficiency in the biopharmaceutical industry. Their technology uses machine learning to optimize signal peptides, accelerating development and lowering costs for therapies like monoclonal antibodies and mRNA vaccines. This aims to make critical treatments more accessible globally.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: $2.5M
Date: 22-Oct-2024
Investors: Voima Ventures, Inventure, US angel investors
Markets: Biotechnology, Pharmaceuticals, Biotechnology Research, HealthTech, Manufacturing, Drug Discovery, Other Healthcare Services, Discovery Tools (Healthcare), Other Healthcare Technology Systems
HQ: Palo Alto, California, United States
Founded: 2023
Website: https://www.avenuebiosciences.com/
LinkedIn: https://www.linkedin.com/company/avenue-biosciences
Crunchbase: https://www.crunchbase.com/organization/avenue-biosciences
Leave a Comment
Comments
No comments yet.